Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

United States Antimony (UAMY) EBT (2016 - 2025)

United States Antimony's EBT history spans 15 years, with the latest figure at $4.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 552.05% to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$75684.0, a 95.82% increase, with the full-year FY2025 number at -$4.3 million, down 329.68% from a year prior.
  • EBT hit $4.0 million in Q4 2025 for United States Antimony, up from -$4.8 million in the prior quarter.
  • Over the last five years, EBT for UAMY hit a ceiling of $4.0 million in Q4 2025 and a floor of -$4.8 million in Q3 2025.
  • Historically, EBT has averaged -$247558.4 across 5 years, with a median of -$143153.5 in 2021.
  • Biggest five-year swings in EBT: tumbled 2962.21% in 2022 and later skyrocketed 803.56% in 2024.
  • Tracing UAMY's EBT over 5 years: stood at $37110.0 in 2021, then tumbled by 2962.21% to -$1.1 million in 2022, then dropped by 19.25% to -$1.3 million in 2023, then skyrocketed by 30.73% to -$877331.0 in 2024, then skyrocketed by 552.05% to $4.0 million in 2025.
  • Business Quant data shows EBT for UAMY at $4.0 million in Q4 2025, -$4.8 million in Q3 2025, and $174777.0 in Q2 2025.